Swetha Kambhampati Thiruvengadam

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies

Zainab Shahid, Tania Jain, M. Veronica Dioverti et al. · Transplantation and Cellular Therapy · 2024 · 81 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma

Swetha Kambhampati Thiruvengadam, Alan H. Tieu, Brandon Luber et al. · Scientific Reports · 2020 · 63 citations · Full text

Medicine, Oncology, Gastroenterology +13

Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma

Rahul Banerjee, Jeffrey Marsal, Chiung‐Yu Huang et al. · Transplantation and Cellular Therapy · 2021 · 48 citations

Life Sciences, Immunology, Pharmacology +15

Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis

Robert A. Moran, Niloofar Y. Jalaly, Ayesha Kamal et al. · Pancreatology · 2016 · 18 citations

Medicine, Internal Medicine, Host-pathogen Interactions +7

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Pallawi Torka, Swetha Kambhampati Thiruvengadam, Lu Chen et al. · Blood Cancer Journal · 2023 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14